Company: ABBV
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0001558370-25-002603
Chunk: 82

Company: AbbVie Inc.
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 82
---
, and (iii) 68,258 AbbVie performance shares with a value of $12,795,342. |

| ● | Dr. Saleki-Gerhardt would have vested in (i) 56,292 unvested AbbVie stock options with a value of $887,817, (ii) 44,452 AbbVie restricted stock units with a value of $8,182,246, and (iii) 52,841 AbbVie performance shares with a value of $9,927,654. |

| ● | Mr. Richmond would have vested in (i) 55,302 unvested AbbVie stock options with a value of $868,100, (ii) 43,899 AbbVie restricted stock units with a value of $8,079,004, and (iii) 52,012 AbbVie performance shares with a value of $9,772,886. |

The value of stock options shown is based on the excess of the closing price of one share of common stock on December 31, 2024 over the exercise price of such options, multiplied by the number of unvested stock options held by the NEO. The value of restricted stock units and performance shares shown is determined by multiplying the number of units or shares (at target level for performance-based awards) that would vest as of December 31, 2024 in accordance with the applicable equity award agreement terms and the closing price of one share of common stock on December 31, 2024. The value of restricted stock units and performance shares also includes the value of accrued dividends as of December 31, 2024, which would be paid at vesting.

2025 Proxy Statement |71

RATIFICATION OF ERNST & YOUNG LLP AS ABBVIE’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The audit committee of the Board of Directors is directly responsible for the appointment, fees, retention and oversight of the independent registered public accounting firm retained to audit the company’s financial statements. On October 8, 2024, the audit committee appointed Ernst & Young LLP (the independent auditor) to perform independent audit services for the fiscal year ending December 31, 2025. Ernst & Young LLP has served as our independent auditor since 2013. In conjunction with the periodic mandated rotation of the audit firm’s lead engagement partner, the chair of the audit committee would be involved in the selection of a new lead engagement partner.